SCHEMBL10179358

SCHEMBL10179358

CS(=O)(=O)c1cc2cc[nH]c2c(F)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.41
▸ PGR P06401 1/20 0.41
▸ NR3C2 P08235 1/20 0.41
▸ AR P10275 1/20 0.41
▸ PTGS2 P35354 1/20 0.36
▸ IKBKB O14920 1/20 0.35
▸ CHUK O15111 1/20 0.35
▸ ALOX5AP P20292 3/20 0.33
▸ FEN1 P39748 3/20 0.33
▸ ACLY P53396 1/20 0.33
▸ TNF P01375 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ CCR2 P41597 2/20 0.32
▸ BRD4 O60885 2/20 0.32
▸ TAF1 P21675 1/20 0.32
▸ BRPF1 P55201 1/20 0.32
▸ CREBBP Q92793 1/20 0.32
▸ CECR2 Q9BXF3 1/20 0.32
▸ BRD9 Q9H8M2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10180291 0.75 P2RX7 (0.37) NR3C1PGRNR3C2ARPTGS2
SCHEMBL10179553 0.72 GPR84 (0.58) ALOX5APFEN1GPR84CCR2AHR
SCHEMBL8533144 0.72 PTGS2 (0.43) NR3C1PGRNR3C2ARPTGS2
SCHEMBL18876057 0.72 TNF (0.38) NR3C1PGRIKBKBCHUKTNF
SCHEMBL2535930 0.71 GPR84 (0.50) ARIKBKBCHUKTNFRIPK1
SCHEMBL593678 0.69 NR3C1 (0.62) NR3C1PGRNR3C2ARACLY
SCHEMBL10179175 0.68 CSNK2A1 (0.41) IKBKBCHUKTNFRIPK1GPR84
SCHEMBL1741436 0.68 TNF (0.38) IKBKBCHUKTNFRIPK1GPR84
SCHEMBL29991075 0.68 TNF (0.47) NR3C1PGRIKBKBCHUKTNF
SCHEMBL1349668 0.67 AHR (0.37) NR3C1PGRNR3C2ARPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190192510-A1 GPR119 AGONIST NIPPON CHEMIPHAR CO., LTD. (JP) 2019-06-27 — — US disclosed
EP-2532656-A1 GPR119 AGONIST Nippon Chemiphar Co., Ltd. (JP) 2012-12-12 — — EP disclosed
US-20120245344-A1 GPR119 AGONIST NIPPON CHEMIPHAR CO., LTD. (JP) 2012-09-27 — — US disclosed
EP-2474540-A1 GPR119 AGONIST Nippon Chemiphar Co., Ltd. (JP) 2012-07-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190192510-A1 GPR119 AGONIST GPR119, GPR4, GPR27 NR3C1 185/4885PGR 527/4885NR3C2 241/4885
US-20120245344-A1 GPR119 AGONIST GPR119, GPR4, GPR55 NR3C1 253/4885PGR 648/4885NR3C2 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback